Transcriptome network analysis reveals potential candidate genes for squamous lung cancer

International Journal of Molecular Medicine

Volumn 29, Issue 1, 2012, Pages 95-101

  Bai, Jing ^a   Hu, Sheng ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI CANCER HOSPITAL   (China)

Author keywords

Squamous lung cancer; Transcription factor; Transcriptome network analysis

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN FOS; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ARTICLE; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; MICROARRAY ANALYSIS; PRIORITY JOURNAL; SQUAMOUS LUNG CANCER; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; GENE REGULATORY NETWORKS; HUMANS; LUNG NEOPLASMS; MODELS, GENETIC; NEOPLASMS, SQUAMOUS CELL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84855169962     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.796     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Travis WD: Pathology of lung cancer. Clin Chest Med 23: 65-81, viii, 2002.
3. Kim HS, Park K, Jun HJ, et al.: Comparison of survival in advanced non-small cell lung cancer patients in the pre- and post-gefitinib eras. Oncology 76: 239-246, 2009.
4. Reinmuth N, Mesters RM, Bieker R, Hoffknecht P, Berdel WE and Thomas M: Signal transduction pathways as novel therapy targets in lung cancer. Lung Cancer 45 (Suppl 2): 177-186, 2004.
5. Yagui-Beltran A, He B, Raz D, Kim J and Jablons DM: Novel therapies targeting signaling pathways in lung cancer. Thorac Surg Clin 16: 379-396, vi, 2006.
6. Daniel VC, Peacock CD and Watkins DN: Developmental signalling pathways in lung cancer. Respirology 11: 234-240, 2006.
7. Denlinger CE, Rundall BK and Jones DR: Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-kappaB. Semin Thorac Cardiovasc Surg 16: 28-39, 2004. (Pubitemid 38714757)
8. Stabile LP and Siegfried JM: Estrogen receptor pathways in lung cancer. Curr Oncol Rep 6: 259-267, 2004. (Pubitemid 39359495)
9. Wachi S, Yoneda K and Wu R: Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 21: 4205-4208, 2005. (Pubitemid 41724298)
10. Kanehisa M: The KEGG database. Novartis Found Symp 247: 91-252, 2002.
11. Brivanlou AH and Darnell JE Jr: Signal transduction and the control of gene expression. Science 295: 813-818, 2002. (Pubitemid 34118354)
12. Wingender E: The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Brief Bioinform 9: 326-332, 2008.
13. Jiang C, Xuan Z, Zhao F and Zhang MQ: TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 35: D137-D140, 2007. (Pubitemid 46056185)
14. Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article 3, 2004.
15. Maere S, Heymans K and Kuiper M: BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21: 3448-3449, 2005. (Pubitemid 41222459)
16. Shannon P, Markiel A, Ozier O, et al.: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504, 2003. (Pubitemid 37428274)
17. Draghici S, Khatri P, Tarca AL, et al.: A systems biology approach for pathway level analysis. Genome Res 17: 1537-1545, 2007. (Pubitemid 47529438)
18. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ and Church GM: Systematic determination of genetic network architecture. Nat Genet 22: 281-285, 1999. (Pubitemid 29297256)
19. Draghici S, Khatri P, Martins RP, Ostermeier GC and Krawetz SA: Global functional profiling of gene expression. Genomics 81: 98-104, 2003. (Pubitemid 36298600)
20. Perou CM, Sorlie T, Eisen MB, et al.: Molecular portraits of human breast tumours. Nature 406: 747-752, 2000.
21. Vazquez A, Dobrin R, Sergi D, Eckmann JP, Oltvai ZN and Barabasi AL: The topological relationship between the large-scale attributes and local interaction patterns of complex networks. Proc Natl Acad Sci USA 101: 17940-17945, 2004. (Pubitemid 40054054)
22. Ideker RE, Huang J, Fast V and Smith WM: Recent fibrillation studies: attempts to wrest order from disorder. Circ Res 89: 1089-1091, 2001. (Pubitemid 34627865)
23. Kitano H, Kataoka K, Furukawa K and Hara S: Specific expression and temperature-dependent expression of the acid protease-encoding gene (pepA) in Aspergillus oryzae in solidstate culture (Rice-Koji). J Biosci Bioeng 93: 563-567, 2002. (Pubitemid 34743654)
24. Keshamouni VG, Reddy RC, Arenberg DA, et al.: Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small cell lung cancer. Oncogene 23: 100-108, 2004. (Pubitemid 38142244)
25. Reka AK, Goswami MT, Krishnapuram R, Standiford TJ and Keshamouni VG: Molecular cross-regulation between PPAR-gamma and other signaling pathways: Implications for lung cancer therapy. Lung Cancer 72: 154-159, 2011.
26. Yuan H, Li MY, Ma LT, et al.: 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer. Thorax 65: 321-326, 2010.
27. Choudhary R, Li H, Winn RA, Sorenson AL, Weiser-Evans MC and Nemenoff RA: Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail. Neoplasia 12: 224-234, 2010.
28. Li MY, Yuan H, Ma LT, et al.: Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer. Am J Respir Cell Mol Biol 43: 674-683, 2010.
29. Han S, Ritzenthaler JD, Rivera HN and Roman J: Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1. Am J Physiol Lung Cell Mol Physiol 289: L419-L428, 2005. (Pubitemid 41192717)
30. Dergunoa LV, Raevskaia NM, Volosheniuk EL and Limborskaia SA: Expression peculiarities of EGR1, neurotrophins and their receptor genes in human lung cancer and in normal lung tissue. Mol Gen Mikrobiol Virusol 2007: 25-30, 2007 (In Russian).
31. Burcham PC, Raso A and Thompson CA: Toxicity of smoke extracts towards A549 lung cells: role of acrolein and suppression by carbonyl scavengers. Chem Biol Interact 183: 416-424, 2010.
32. Parra E and Ferreira J: The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines. Oncol Rep 23: 1159-1165, 2010.
33. Fang L, Min L, Lin Y, et al.: Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549. Cell Signal 22: 166-173, 2010.
34. Shimoyamada H, Yazawa T, Sato H, et al.: Early growth response-1 induces and enhances vascular endothelial growth factor-A expression in lung cancer cells. Am J Pathol 177: 70-83, 2010.
35. Sato Y, Yamamoto N, Kunitoh H, et al.: Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel. J Thorac Oncol 6: 132-138, 2011.
36. Ming J, Zhang Q, Qiu X and Wang E: Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer. Eur J Cancer 45: 866-873, 2009.
37. Zhao Z, Cheng Q, Li X, Wang X and Liu K: c-fos antisense oligodeoxynucleotide reduces VIP-induced upregulation of VEGF expression in small cell lung cancer cells. Zhongguo Fei Ai Za Zhi 9: 312-315, 2006 (In Chinese). (Pubitemid 44306279)
38. Guney N, Soydinc HO, Derin D, et al.: Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer. Med Oncol 25: 194-200, 2008.
39. Dabrowska M, Grubek-Jaworska H, Hoser G, Domagala-Kulawik J, Krenke R and Chazan R: Effect of IFN-gamma stimulation on expression of intercellular adhesion molecule-1 (ICAM-1) on alveolar macrophages in patients with non-small cell lung cancer. J Interferon Cytokine Res 26: 190-195, 2006.